Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
- Conditions
- Amyotrophic Lateral Sclerosis
- Registration Number
- NCT05852418
- Lead Sponsor
- Ambulanzpartner Soziotechnologie APST GmbH
- Brief Summary
This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with Amyotrophic lateral sclerosis (ALS), Spinal muscular atrophy (SMA) and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes.
- Detailed Description
This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with ALS, SMA and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes. The collected data include clinical characteristics, medical history, assessment scales, such as ALS functional rating scale-revised (ALSFRS-R), prognosis indicators, such as ALS progression rate, biomarker data, such as serum Neurofilament light chain (sNfL), genetic data, such as the mutation status of SOD1, FUS, c9orf72, TARDBP in ALS, SMN1 in SMA patients, innovative drugs such as Tofersen, Nusinersen, Risdiplam, as well as symptomatic drugs, patient-reported outcome data being captured using questionnaires and established clinical scales on medication expectation and treatment satisfaction.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 25000
Diagnosis of a chronic neurological disease -
Lack of cooperation and unwillingness to store and share medical data collected in the registry study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The systematic recording of neurological treatment and its evaluation by patients via specific questionnaires 10 years The systematic recording of neurological treatment and its evaluation by patients via specific questionnaires
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (16)
Christoph Münch
🇩🇪Berlin, Germany
Klinik für Neurodegenrative Erkrankungen und Gerontopsychiatrie, ALS-Ambulanz und Huntington Ambulanz, Universitätsklinikum
🇩🇪Bonn, Germany
Neurologische Klinik, ALS-Ambulanz, Alfried Krupp Krankenhaus Rüttenscheid, Essen
🇩🇪Essen, Germany
Ambulanz für Neuromuskuläre und Motoneuron-Erkrankungen, Universitätsklinikum Jena
🇩🇪Jena, Germany
Universitätklinikum
🇩🇪Mannheim, Germany
Klinik für Neurologie, Universitätsmedizin, Georg-August-Universität Göttingen
🇩🇪Göttingen, Germany
Neurologie und Poliklinik, Universitätsklinikum
🇩🇪Heidelberg, Germany
Klinik und Poliklinik für Neurologie
🇩🇪Leipzig, Germany
Neurologisches Klinik, Ambulanz für Motoneuronerkrankungen und ALS, Diakonissenkrankenhaus
🇩🇪Mannheim, Germany
Klinik und Poliklinik für Neurologie, Medizinische Fakultät Carl Gustav Carus, Technischen Universität Dresden
🇩🇪Dresden, Germany
Neurologische Klinik und Poliklinik, Universitätsklinikum Bergmannsheil
🇩🇪Bochum, Germany
ALS- und Muskelambulanz, Medizinische Hochschule Hannover
🇩🇪Hannover, Germany
Klinik für Neuroogie-Präzisionsneurologie, Universitätsklinikum Schleswig-Holstein, Universität zu Lübeck
🇩🇪Lübeck, Germany
Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen, Westfälische Willhelms-Universität Münster
🇩🇪Münster, Germany
Klinik für Innere Medizin, Neurologie, UKM Marienhospital Steinfurt
🇩🇪Steinfurt, Germany
Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar der Technischen Universität München
🇩🇪München, Germany